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Objective To evaluate the impact of nephrectomy on 
renal function in people who are potential candidates 
for nephron sparing surgery, i.e. partial nephrectomy. 
Patients and methods A retrospective analysis was 
carried out of 109 patients (35 women, 74 men) who 
had undergone a nephrectomy for stage I renal carci- 
noma at the University of Michigan between 1960 
and 1979. All patients had a functioning contralateral 
kidney and had undergone at least one post-operative 
serum creatinine evaluation. Statistical analysis was 
by Pearson’s correlation coefficient. 
Results One individual developed a transitional cell car- 
cinoma in the remaining renal pelvis and was treated 
with nephroureterectomy. No other patient progressed 
to dialysis. Five patients had post-operative serum 
creatinine levels from 22 1 to 3 54 pmol/l, one of whom 
had undergone both a nephrectomy and a partial 
nephrectomy for bilateral renal tumours. The remain- 
ing four had renal disease including diabetes, hyper- 
tension, pyelonephritis and renal artery stenosis. There 
was a strong association between pre-operative and 
post-operative serum creatinine values. 
Conclusion Patients with low stage renal tumours and 
a normal contralateral kidney are at low risk of 
progression to renal failure. 
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Introduction 
The most commonly employed treatment for renal cancer 
continues to be nephrectomy. This method of treatment 
offers the advantage of wide local excision but sacrifices 
some normal renal parenchyma. Individuals with a 
normal contralateral kidney do not appear to suffer acute 
problems from this method of therapy. However, the 
potential for adverse effects in patients with compromised 
renal reserve or a predilection for bilateral neoplasms, 
e.g. von Hippel-Lindau disease, has resulted in the explo- 
ration of alternative methods of therapy. The successful 
application of partial nephrectomy in this patient popu- 
lation has led to its use in selected individuals with small 
tumours and a normal contralateral kidney. One import- 
ant factor in choosing between radical and partial neph- 
rectomy in a patient with a small solid renal mass and 
a normal contralateral kidney is the long-term effect of 
losing a renal unit. We performed a retrospective analysis 
of patients who had undergone radical nephrectomy to 
determine the long-term outcome of this surgery on 
their renal status. 
Patients and methods 
Between 1960 and 1979 165 patients underwent surgi- 
cal excision of stage I renal carcinomas at the University 
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of Michigan. Criteria for inclusion in this report included 
a nephrectomy, a functioning contralateral kidney and 
at least one follow-up creatinine evaluation after dis- 
charge from the hospital. From the initial population, 
109 patients (35 women, 74 men) met these eligibility 
criteria and form the basis of this report. Serum creatin- 
ine measurements were not regularly obtained in all 
patients. For those individuals with sporadic values, renal 
function was assumed to have remained stable from the 
time of surgery or previous post-operative serum creatin- 
ine evaluation to the most recent evaluation. Follow-up 
is defined as the time interval from nephrectomy to the 
most recent serum creatinine evaluation. 
Association between pre-operative and post-operative 
serum creatinine values was assessed using Pearson’s 
correlation coefficient. The same method was used to 
determine whether there was an association between 
post-operative serum creatinine values and possible con- 
founding variables such as follow-up time, age and year 
of nephrectomy. A P value of GO.05 was taken to 
indicate signscance. 
Results 
One of the 109 individuals progressed to renal failure. 
This individual developed a transitional cell carcinoma 
in his remaining renal pelvis 10 months after the initial 
nephrectomy. After nephroureterectomy he was main- 
tained on dialysis. 
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The remaining 108 patients did not have any clinical 
disability related to loss of normal renal parenchyma. 
Follow-up ranged from < 1 month to 23.5 years with a 
mean of 3.2 years. The median creatinine value at 
follow-up was 124 pmol/l. At the most recent follow- 
up 70% of the patients had serum creatinine values 
of < 133 pmol/l, 19% had values ranging from 141 
to 177 pmol/l, and 11% had creatinine values 
> 177 pmol/l. There were five individuals with follow- 
up serum creatinine values of 2 2 2 1  pmol/l (Table 1). 
One presented with bilateral synchronous renal tumours 
and underwent a unilateral nephrectomy and a partial 
nephrectomy. The others had medical conditions which 
may have contributed to their renal deterioration includ- 
ing diabetes, hypertension, chronic pyelonephritis, 
staghorn calculi and renal artery stenosis. Three indi- 
viduals with follow-up serum creatinine values of 
> 265 pmol/l had pre-operative values of 150. 194 and 
239 pmol/l. 
Follow-up creatinine is plotted against follow-up time 
in Fig. 1. If all patients are considered, there was a 
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marginally significant tendency for patients with highcr 
creatinine values to be followed for a short period 0 1  
t i e  ( r =  -0.19, P=O.05) .  There were three highly 
influential observations in individuals with recent creali- 
nine values of 2 26 5 pmol/l. When these observations 
were excluded, the correlation coefficient was reduced 
to -0.14 and its significance fell to P=0.15. There was 
a slight but statistically significant association between 
creatinine value and age (r=0.21, P=O.O3).  Creatininc 
values were significantly lower for women than for men 
(women: %=1.3, SE=O.OS: men: X =  1.6, s~=0.06:  P =  
0.007). None of the 35 women had a creatinine valuc 
that exceeded 177 pmol/l while 16% of the 74 men had 
creatinine values of that magnitude. There was no 
statistically significant association between the most 
recent creatinine value and the year of nephrectomy 
( r  =0.15, P = 0.1 3). 
Both pre-operative and follow-up serum creatinino 
measurements were available for 87 patients. There was 
a strong association (Fig. 2) between pre-operative and 
follow-up serum creatinine values (r=0.63, P<O.OOl). 
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Table I 
Post-operative Pre-operative 
creatinine creatininr Age Follow-up Medical problems 
(pmolllj (pmolll) (years) (months) 
0 
I I I 1 1 -  I 
~~~~ ~ ~ ~ ~ 
3 54  194 67 7 Diabetes and hypertension 
2 7 4  150  65 6 Bilateral tumours. nephrectomy and 
265 239 55 17 Chronic pyelonephritis and 
2 30 124 75  14 70% stenosis of remaining 
221 1 3 3  63 23 Diabetes and hypertension 
partial nephrectomy 
bilateral staghorn calculi 
renal artery 
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The strength of this association persisted even when the 
individuals who had post-operative creatinine values of 
2 26 5 pmol/l were excluded from the analysis. 
Discussion and conclusions 
Nephrectomy continues to be the most common surgical 
approach to the treatment of localized renal carcinoma. 
However, increasing attention is being focused on the 
role of parenchyma sparing approaches, particularly 
partial nephrectomy, as an alternative form of therapy. 
Partial nephrectomy and/or tumour enucleation have 
been successful in patients with one functioning kidney 
and those at high risk of bilateral disease, e.g. patients 
with von Hippel-Lindau disease [l]. The effectiveness of 
parenchyma sparing surgery in this clinical setting has 
led to the use of partial nephrectomy in patients with 
low stage tumours and a normal contralateral kidney 
[2- 51. Although the preservation of renal parenchyma 
is intuitively appealing, the employment of this strategy 
in patients with low stage renal carcinoma and a normal 
contralateral kidney should be based on a rational 
evaluation of the risks and benefits. The major benefit of 
this approach is the preservation of normal renal paren- 
chyma. An aura of controversy surrounds the hypothesis 
that glomerular hypefiltration occurring after neph- 
rectomy contributes to long-term renal deterioration. 
However, the major disadvantage of less than complete 
renal excision is the increased risk of local recurrence. 
While theoretically the probability of local recurrence is 
high (6, 71. clinical data suggests that the true incidence 
of this phenomenon in appropriately selected individuals 
is 6% or less [l-51. This is similar to the 7% incidence 
of multifocal renal cancer found when nephrectomy 
specimens are serially sectioned [8]. 
A retrospective evaluation was performed of 109 
individuals who had adequate renal function and a 
nephrectomy for stage I renal cancer. Only one person 
(0.9%) required dialysis. This individual developed a 
transitional cell carcinoma in the contralateral kidney 
which was treated with nephroureterectomy. Post- 
operative serum creatinine strongly correlated with the 
pre-operative values. Five patients had a post-operative 
serum creatinine 2 22 1 pmol/l. One of these patients 
presented with bilateral synchronous renal tumours and 
was treated with a nephrectomy and partial nephrec- 
tomy. The remaining four patients had medical diseases 
including diabetes, hypertension and renal artery sten- 
osis, which may have contributed to their deterioration 
in renal function. 
The excellent long-term renal function in the patients 
reported here is similar to the experience reported by 
Wishnow et al. [9]. In their series of 56 patients who 
were followed for more than 115 months after radical 
nephrectomy, only two individuals had a serum creatin- 
ine > 141 pmol/l. The individual with a creatinine value 
> 177 pmol/l also had a predisposing medical condition, 
i.e. diabetes. Novick et al. reported on a series of 12 
patients who had undergone partial nephrectomy in a 
solitary kidney [lo]. In this group of patients who had 
a relatively small volume of normal parenchyma remain- 
ing (25-75% of a single kidney), progressive renal 
insufficiency requiring dialysis occurred in only two 
patients. While mild to moderate proteinuria was 
common, the remaining patients had stable renal func- 
tion with only two having serum creatinine levels 
> 177 pmol/l (239 and 248 pmol/l). Higashihara et al. 
presented a large series of patients who had nephrectomy 
or congenital renal agenesis [7]. This group also demon- 
strated that urinary protein excretion increases with 
time following nephrectomy. However, despite this labor- 
atory abnormality, these patients did not develop 
increases in serum creatinine or hypertension and 
did not develop clinical problems related to renal 
deterioration. 
There is little controversy regarding partial nephrec- 
tomy in individuals who have a renal neoplasm in a 
solitary kidney or a poorly functioning contralateral 
kidney and those individuals at risk of multifocal neo- 
plasia, i.e. von Hippel-Lindau disease. There continues 
to be controversy regarding the appropriateness of partial 
nephrectomy in individuals with low stage renal carci- 
nomas and a normal contralateral kidney. The present 
data and that of others suggest that people with a 
normal contralateral kidney rarely suffer ill consequences 
as a result of their nephrectomy and do not manifest a 
need for more renal parenchyma. This global statement 
may not be true for those at risk of medical renal disease, 
such as individuals with diabetes or hypertension. While 
partial nephrectomy may be the most conservative 
approach in this latter population, the widespread use 
of this technique in healthy individuals with renal neo- 
plasms should await more data describing the risks of 
local recurrence in low stage renal cancer. 
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